Melanoma of unknown primary associated with similar survival as cutaneous primary
Source: Healio, January 2023
Despite more frequent poor prognostic factors, melanoma of unknown primary etiology was not associated with poorer survival than melanoma of known cutaneous etiology, according to a study.
“Clinical outcomes of advanced melanoma of unknown primary in the era of novel therapies have been scarcely studied,” Perrine Rousset, MD, of the dermatology department at the University Hospital of Nice in France, and colleagues wrote.
The study used data from the French nationwide MelBase database to assess the efficacy and safety of systemic therapies in patients with melanoma of unknown primary etiology. These findings were then compared with staged-matched data for patients with melanoma with known cutaneous primary etiology.